ENXTBR:PAY
ENXTBR:PAYElectronic

European Dividend Stocks To Watch Now

As European markets show signs of steady economic growth and benefit from looser monetary policy, the pan-European STOXX Europe 600 Index recently climbed by 1.60%, with major stock indexes also experiencing gains. In this environment, dividend stocks can be particularly appealing to investors looking for income stability and potential capital appreciation, as they often represent companies with strong financial health and consistent cash flow.
ENXTBR:BEKB
ENXTBR:BEKBMetals and Mining

European Dividend Stocks To Consider For Your Portfolio

As European markets show signs of steady economic growth and benefit from looser monetary policies, the pan-European STOXX Europe 600 Index has seen a notable rise, reflecting investor optimism. In this environment, dividend stocks can be an attractive option for those seeking regular income streams, as they often provide stability and potential returns even amid fluctuating market conditions.
ENXTBR:UMI
ENXTBR:UMIChemicals

Assessing Umicore’s (ENXTBR:UMI) Valuation After a 22% One-Month Share Price Rebound

Umicore (ENXTBR:UMI) has quietly staged a strong comeback, with the share price up around 22% over the past month and roughly 24% in the past 3 months, catching investors attention. See our latest analysis for Umicore. Zooming out, the recent 22 percent 1 month share price return at a last close of 17.87 euros sits on top of a powerful year to date share price gain of roughly 76 percent. However, the 3 year total shareholder return is still deeply negative, suggesting momentum has returned as...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

Did Halting UplighTED Trials in Thyroid Eye Disease Just Shift argenx's (ENXTBR:ARGX) Investment Narrative?

In December 2025, argenx SE halted its Phase 3 UplighTED studies of subcutaneous efgartigimod in adults with moderate to severe thyroid eye disease after an Independent Data Monitoring Committee concluded the trials were unlikely to meet their primary efficacy endpoint, despite a favorable safety profile. This setback in a key late-stage indication may sharpen investor focus on the resilience of argenx’s broader autoimmune pipeline and its reliance on future label expansions to drive...
ENXTBR:094426466
ENXTBR:094426466Metals and Mining

Has SCR-Sibelco’s Recent 18.6% Surge Left Its Valuation Too Stretched?

Wondering if SCR-Sibelco is still a bargain or if the easy money has already been made? This breakdown will help you cut through the noise and focus on what the current price really implies. The stock has climbed 8.5% over the last week, 9.9% over the past month, and is up 18.6% over the last year, which has sharpened investor interest in its upside and risk profile. Recent attention has centred on SCR-Sibelco's strategic positioning in industrial minerals, including ongoing portfolio...
ENXTBR:ONWD
ENXTBR:ONWDMedical Equipment

Inmocemento Leads The Charge In Our European Penny Stock Spotlight

As European markets show signs of steady economic growth and benefit from looser monetary policy, the pan-European STOXX Europe 600 Index has risen by 1.60%, with major stock indexes also seeing gains. In this context, penny stocks—often representing smaller or newer companies—remain a relevant area for investors seeking unique opportunities beyond the more established names. While traditionally associated with higher risk, certain penny stocks stand out due to their financial resilience and...
ENXTBR:ABI
ENXTBR:ABIBeverage

Assessing Anheuser-Busch InBev (ENXTBR:ABI) Valuation After U.S. Brewery Closures and Production Consolidation

Anheuser-Busch InBev (ENXTBR:ABI) has investors talking after announcing plans to close its Fairfield and Merrimack breweries and sell its Newark facility, consolidating U.S. production to sharpen efficiency and support higher growth brands. See our latest analysis for Anheuser-Busch InBev. The consolidation news lands after a solid run, with an 11.43% 3 month share price return and a 16.87% one year total shareholder return suggesting momentum is quietly rebuilding around the story. If this...
ENXTBR:ABI
ENXTBR:ABIBeverage

ICC Beer Partnership Focused on Budweiser 0.0 Could Be A Game Changer For Anheuser-Busch InBev (ENXTBR:ABI)

Earlier in December 2025, the International Cricket Council announced that AB InBev will become the Official Beer Partner for all major ICC tournaments from 2026 to 2027, led by Budweiser 0.0 in India and supported by other brands across Europe and Africa. This partnership places AB InBev’s no-alcohol and lower-ABV portfolio at the heart of global cricket events, expanding exposure to millions of fans across key beer-drinking markets. We’ll now examine how this ICC partnership, centered on...
ENXTBR:ONTEX
ENXTBR:ONTEXPersonal Products

Ontex Group (ENXTBR:ONTEX) Is Down 25.3% After CEO Transition And Revenue Cut News – Has The Bull Case Changed?

Ontex Group has announced that Europe Division President Laurent Nielly will succeed Gustavo Calvo Paz as CEO after the May 5, 2026 shareholders’ meeting, while also cutting its 2025 revenue outlook and warning of a high single digit like-for-like revenue drop in the fourth quarter versus last year. At the same time, Ontex is tripling baby pants production capacity in North America to support retailer-brand growth in a segment where U.S. consumers are increasingly opting for affordable,...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

argenx (ENXTBR:ARGX): Assessing Valuation Ahead of Antibody Engineering & Therapeutics Conference Updates

argenx (ENXTBR:ARGX) heads into the Antibody Engineering and Therapeutics conference in San Diego, with investors watching closely for fresh signals on its antibody pipeline and what that might mean for the stock. See our latest analysis for argenx. The conference buzz comes after a strong run for argenx, with the share price now at $753.2 and a roughly 18% 3 month share price return contributing to a 106% three year total shareholder return. This suggests momentum is still very much on its...
ENXTBR:DEME
ENXTBR:DEMEConstruction

How New BC-Wind Contracts Could Shape DEME Group’s (ENXTBR:DEME) Offshore Wind Investment Narrative

DEME Group has recently secured three contracts to install monopile foundations, inter-array cables and an export cable for the BC-Wind offshore wind farm in Poland, reinforcing its role in the country’s renewable energy rollout. These wins further deepen DEME’s exposure to offshore wind infrastructure, expanding its project pipeline in a market focused on accelerating its energy transition. We’ll now examine how securing BC-Wind’s foundation and cable installation work could influence...